Search
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers
Abstract
Traditional small-molecule chemotherapeutics usually do not distinguish tumors from healthy tissues. However, nanotechnology creates nanocarriers that selectively deliver drugs to their site of action. This work is the next step in the development of the quantum dot−β−cyclodextrin−folic acid (QD−β−CD−FA) platform for targeted and selected delivery of C−2028 unsymmetrical bisacridine in cancer therapy.Herein, we report an initial biological evaluation (using flow cytometry and light microscopy) as well as cell migration analysis of QD−β−CD(C−2028)−FA nanoconjugate and its components in the selected human lung and prostate cancer cells, as well as against their respective normal cells. C−2028 compound induced apoptosis, which was much stronger in cancer cells compared to normal cells. Conjugation of C−2028 with QDgreen increased cellular senescence, while the introduction of FA to the conjugate significantly decreased this process. C−2028 nanoencapsulation also reduced cell migration. Importantly, QDgreen and QDgreen−β−CD−FA themselves did not induce any toxic responses in studied cells. In conclusion, the results demonstrate the high potential of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier (QDgreen−β−CD−FA) for drug delivery in cancer treatment. Nanoplatforms increased the amount of delivered compounds and demonstrated high suitability.
Citations
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Authors (8)
-
-
Patrycja Kowalik
- Polska Akademia Nauk w Warszawie, Instytut Chemii Fizycznej
-
Agata Kowalczyk
- Uniwersytet Warszawski, Wydział Chemii, Zakład Chemii Nieorganicznej i Analitycznej
-
Piotr Bujak
- Politechnika Warszawska, Wydział Chemiczny, Katedra Chemii i Technologii Polimerów
-
Artur Kasprzak
- Politechnika Warszawska, Wydział Chemiczny, Katedra Chemii Organicznej
-
Anna Maria Nowicka
- Uniwersytet Warszawski, Wydział Chemii, Zakład Chemii Nieorganicznej i Analitycznej
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.1007/s43440-024-00606-4
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Pharmacological Reports
no. 76,
pages 823 - 837,
ISSN: 1734-1140 - Language:
- English
- Publication year:
- 2024
- Bibliographic description:
- Pilch J., Potęga A., Kowalik P., Kowalczyk A., Bujak P., Kasprzak A., Paluszkiewicz E., Nowicka A. M.: In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers// Pharmacological Reports -Vol. 76, (2024), s.823-837
- DOI:
- Digital Object Identifier (open in new tab) 10.1007/s43440-024-00606-4
- Sources of funding:
- Verified by:
- Gdańsk University of Technology
seen 68 times
Recommended for you
Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells
- J. Pilch,
- P. Kowalik,
- A. Kowalczyk
- + 5 authors
Quantum Dots as a Good Carriers of Unsymmetrical Bisacridines for Modulating Cellular Uptake and the Biological Response in Lung and Colon Cancer Cells
- J. Pilch,
- P. Kowalik,
- P. Bujak
- + 2 authors
New Unsymmetrical Bisacridine Derivatives Noncovalently Attached to Quaternary Quantum Dots Improve Cancer Therapy by Enhancing Cytotoxicity toward Cancer Cells and Protecting Normal Cells
- J. Pilch,
- E. Matysiak-Brynda,
- A. Kowalczyk
- + 4 authors